FGF21 and obesity due to melanocortin 4 receptor deficiency: This phenomenon of reduced FGF21 action in obesity has been attributed to an abnormal reduction in the expression of the FGF21 co-receptor, β-Klotho, in white adipose tissue, commonly observed in rodent models of obesity and in obese individuals (30).